1 completed, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow HER2-Negative Locally Advanced Breast Cancer: new trials by email Literature Review of HER2-Negative Locally Advanced Breast Cancer trials Research Report on HER2-Negative Locally Advanced Breast Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluate the Efficacy and Safety of Adebrelimab Combined With Chemotherapy With or Without Radiotherapy as Neoadjuvant Treatment for HER2-Negative Locally Advanced Breast Cancer Neoadjuvant Chemotherapy Combined with Immunotherapy and Radiotherapy, Neoadjuvant Chemotherapy Combined with Immunotherapy - HER2-Negative Locally Advanced Breast Cancer | Phase 2 | Recruiting | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 170 | 2025-03-31 | 2026-06-10 |
| Study to Compare Vinorelbine In Combination With the mTOR Inhibitor Everolimus vs. Vinorelbin Monotherapy for Second-line Treatment in Advanced Breast Cancer Vinorebine, Everolimus, Vinorelbine - Her2-negative Metastatic Breast Cancer, Her2-negative Locally Advanced Breast Cancer | Phase 2 | Completed | AIO-Studien-gGmbH | 139 | 2012-01-01 | 2017-08-09 |
Breast Neoplasms (1)
Breast Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1)
Everolimus (1) · Immunotherapy (1) · Radiotherapy (1) · Vinorelbine (1)
AIO-Studien-gGmbH (1) · Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1)
China (1) · Germany (1)